We are live on ! Find out more
CA

CoreCap Advisors Portfolio holdings

AUM $3.39B
1-Year Est. Return 31.21%
This Fund
S&P 500
This Quarter Est. Return
+10.24%
1 Year Est. Return
+31.21%
3 Year Est. Return
+83.55%
5 Year Est. Return
10 Year Est. Return
AUM
$2.48B
AUM Growth
+$213M
Cap. Flow
+$15.3M
Cap. Flow %
0.61%
Top 10 Hldgs %
30%
Holding
3,336
New
199
Increased
910
Reduced
948
Closed
579
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPCE icon
3201
Virgin Galactic
SPCE
$332M
-1,251
Closed -$3.79K
SPE
3202
Special Opportunities Fund
SPE
$141M
-393
Closed -$5.63K
SPHB icon
3203
Invesco S&P 500 High Beta ETF
SPHB
$979M
-249
Closed -$19.5K
SPOK icon
3204
Spok Holdings
SPOK
$220M
-15
Closed -$247
SPR
3205
DELISTED
Spirit AeroSystems
SPR
-9
Closed -$310
SPRO icon
3206
Spero Therapeutics
SPRO
$67.2M
-50
Closed -$36
SPRY icon
3207
ARS Pharmaceuticals
SPRY
$596M
-41
Closed -$516
SQM icon
3208
Sociedad Química y Minera de Chile
SQM
$19.8B
-185
Closed -$7.35K
SQQQ icon
3209
ProShares UltraPro Short QQQ
SQQQ
$2.14B
-30
Closed -$5.75K
STBA icon
3210
S&T Bancorp
STBA
$1.83B
-6
Closed -$222
STEP icon
3211
StepStone Group
STEP
$3.32B
-6
Closed -$313
STKL
3212
DELISTED
SunOpta
STKL
-2,070
Closed -$10.1K
STNE icon
3213
StoneCo
STNE
$2.67B
-56
Closed -$587
SYRE icon
3214
Spyre Therapeutics
SYRE
$8.68B
-41
Closed -$662
TBPH icon
3215
Theravance Biopharma
TBPH
$874M
-27
Closed -$241
TCRX icon
3216
TScan Therapeutics
TCRX
$55.3M
-166
Closed -$229
TDV icon
3217
ProShares S&P Technology Dividend Aristocrats ETF
TDV
$265M
-254
Closed -$18.5K
TDW icon
3218
Tidewater
TDW
$3.85B
-13
Closed -$550
TECS icon
3219
Direxion Daily Technology Bear 3x ETF
TECS
$75M
-10
Closed -$6.32K
TERN
3220
DELISTED
Terns Pharmaceuticals
TERN
-400
Closed -$1.1K
TEX icon
3221
Terex
TEX
$7.83B
-7
Closed -$264
TGI
3222
DELISTED
Triumph Group
TGI
-11
Closed -$279
TGTX icon
3223
TG Therapeutics
TGTX
$8.5B
-18
Closed -$710
THQ
3224
abrdn Healthcare Opportunities Fund
THQ
$771M
-4,300
Closed -$88.8K
THRD
3225
DELISTED
Third Harmonic Bio
THRD
-123
Closed -$427

Similar funds

CoreCap Advisors's Q2 2025 Portfolio in Review

As of Q2 2025, CoreCap Advisors held 3,336 positions worth $2.48B, up 9.4% from $2.27B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

CoreCap Advisors's Q2 2025 filing shows 199 new, 910 increased, 948 reduced and 579 closed positions. Its largest new stake was iShares MSCI Austria ETF: 118,238 shares worth $3.48M. The largest sale was Vanguard Long-Term Corporate Bond ETF, an estimated $31.7M.

By sector, the portfolio is most concentrated in Technology at 6.8% of assets, up from 6.1% a quarter earlier, followed by Financials and Consumer Discretionary.

  • CoreCap Advisors's largest Q2 2025 buy was iShares MSCI Austria ETF: 118,238 shares worth $3.48M.
  • CoreCap Advisors added most to Vanguard Total Bond Market in Q2 2025, an estimated $28.4M increase.
  • CoreCap Advisors's biggest Q2 2025 reduction was Vanguard Long-Term Corporate Bond ETF, cutting an estimated $31.7M.
  • CoreCap Advisors fully exited Innovator Uncapped Accelerated US Equity ETF in Q2 2025, selling an estimated $2.18M.
  • CoreCap Advisors's ten largest holdings make up 30% of its $2.48B portfolio in Q2 2025.
  • CoreCap Advisors opened 199 new positions and closed 579 in Q2 2025.
  • CoreCap Advisors's portfolio value rose 9.4% quarter-over-quarter to $2.48B.

Based on CoreCap Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.